Erratum: Characterization of recessive RYR1 mutations in core myopathies (Human Molecular Genetics (2006) vol. 15 (2791-2803) 10.1093/hmg/ddl221);Characterization of recessive RYR1 mutations in core myopathies

Human Molecular Genetics

Volumn 15, Issue 18, 2006, Pages 2791-2803

  Zhou, Haiyan ^a   Yamaguchi, Naohiro ^b   Xu, Le ^b   Wang, Ying ^b   Sewry, Caroline ^c   Jungbluth, Heinz ^a,d   Zorzato, Francesco ^e   Bertini, Enrico ^f   Muntoni, Francesco ^a   Meissner, Gerhard ^b   Treves, Susan ^g  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c ROBERT JONES AND AGNES HUNT ORTHOPAEDIC HOSPITAL   (United Kingdom)

^d ST THOMAS HOSPITAL   (United Kingdom)

^e UNIVERSITY OF FERRARA   (Italy)

^f BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^g UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; ASPARAGINE; CALCIUM ION; HISTIDINE; METHIONINE; RYANODINE RECEPTOR; SERINE; TRYPTOPHAN; TYROSINE; VALINE;

AMINO ACID SUBSTITUTION; ARTICLE; CALCIUM CONDUCTANCE; CASE REPORT; CELL STRAIN HEK293; FAMILY; FATHER; GENE MUTATION; GENETIC TRANSCRIPTION; HUMAN; IMMUNOBLOTTING; MYOPATHY; MYOTUBE; PARENT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN STABILITY; RECESSIVE INHERITANCE; SIBLING; SKELETAL MUSCLE;

EID: 33748752700     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddm092     Document Type: Erratum

References (45)

1. Fleischer, S. and Inui, M. (1989) Biochemistry and biophysics of excitation-contraction coupling. Annu. Rev. Biophys. Biophys. Chem., 18, 333-364.
2. Franzini-Armstrong, C. and Jorgensen, A.O. (1994) Structure and development of E-C coupling units in skeletal muscle. Annu. Rev. Physiol., 56, 509-534.
3. Lamb, G.D. and Stephenson, D.G. (1990) Control of calcium release and the effect of ryanodine in skinned muscle fibres of the toad. J. Physiol. (Lond.), 423, 519-542.
4. 2+ release channels and their regulation by endogenous effectors. Annu. Rev. Physiol., 56, 485-508.
5. Phillips, M.S., Fujii, J., Khanna, V.K., DeLeon, S., Yokobata, K., do Jong, P.J. and MacLennan, D.H. (1996) The structural organization of the human skeletal muscle ryanodine receptor (RYR1) gene. Genomics, 34, 24-41.
6. Rios, E. and Pizarro, G. (1991) Voltage sensor of excitation-contraction coupling in skeletal muscle. Physiol. Rev., 71, 849-908.
7. McCarthy, T.V., Quane, K.A. and Lynch, P.J. (2000) Ryanodine receptor mutations in malignant hyperthermia and central core disease. Hum. Mutat., 15, 410-417.
8. Jurkat-Rott, K., McCarthy, T. and Lehmann-Horn, F. (2000) Genetics and pathogenesis of malignant hyperthermia. Muscle Nerve, 23, 4-17.
9. 2+ in malignant hyperthemia and central core disease. Biochem. Biophys. Res. Commun., 322, 1256-1266.
10. Treves, S., Anderson, A.A., Ducreux, S., Divet, A., Bleunven, C., Grasso, C.; Paesante, S. and Zorzato, F. (2005) Ryanodine receptor 1 mutations, dysregulation of calcium homeostasis and neuromuscular disorders. Neuromuscul. Disord., 15, 577-587.
11. Ferreiro, A., Monnier, N., Romero, N.B., Leroy, J.P., Bönnemann, C., Haenggeli, C.A., Straub, V., Voss, W.D., Nivoche, Y., Jungbluth, H. et al. (2002) A recessive form of central core disease, transiently presenting as multi-minicore disease, is associated with a homozygous mutation in the ryanodine receptor type 1 gene. Ann. Neurol, 51, 750-759.
12. Jungbluth, H., Müller, C.R., Halliger-Keller, B., Brockington, M., Brown, S.C., Feng, L., Chattopadhyay, A., Mercuri, E., Manzur, A.Y., Ferreiro, A. et al. (2002) Autosomal recessive inheritance of RYR1 mutations in a congenital myopathy with cores. Neurology, 59, 284-287.
13. Jungbluth, H., Davis, M.R., Muller, C., Counsell, S., Allsop, J., Chattopadhyay, A., Messina, S., Mercuri, E., Laing, N.G., Sewry, C.A., Bydder, G. and Muntoni, F. (2004) Magnetic resonance imaging of muscle in congenital myopathies associated with RYR1 mutations. Neuromuscul. Disord., 14, 785-790.
14. Guis, S., Figarella-Branger, D., Monnier, N., Bendahan, D., Kozak-Ribbens, G., Mattei, J.P., Lunardi, J., Cozzone, P.J. and Pellissier, J.F. (2004) Multiminicore disease in a family susceptible to malignant hyperthermia: Histology, in vitro contracture tests, and genetic characterization. Arch. Neurol., 61, 106-113.
15. Romero, N.B., Monnier, N., Viollet, L., Cortey, A., Chevallay, M., Leroy, J.P., Lunardi, J. and Fardeau, M. (2003) Dominant and recessive central core disease associated with RYR1 mutations and fetal akinesia. Brain, 126, 2341-2349.
16. Zhang, Y., Chen, H.S., Khanna, V.K., De Leon, S., Phillips, M.S., Schappert, K., Britt, B.A., Browell, A.K. and MacLennan, D.H. (1993) A mutation in the human ryanodine receptor gene associated with central core disease. Nat. Genet., 5, 46-50.
17. Davis, M.R., Haan, E., Jungbluth, H., Sewry, C., North, K., Muntoni, F., Kuntzer, T., Lamont, F., Bankier, A., Tomlinson, P. et al. (2003) Principal mutation hotspot for central core disease and related myopathies in the C-terminal transmembrane region of the RYR1 gene. Neuromuscul. Disord., 13, 151-157.
18. Monnier, N., Romero, N.B., Lerale, J., Nivoche, Y., Qi, D., MacLennan, D.H., Fardeau, M. and Lunardi, J. (2000) An autosomal dominant congenital myopathy with cores and rods is associated with a neomutation in the RYR1 gene encoding the skeletal muscle ryanodine receptor. Hum. Mol. Genet., 9, 2599-2608.
19. Monnier, N., Romero, N.B., Lerale, J., Landrieu, P., Nivoche, Y., Fardeau, M. and Lunardi, J. (2001) Familial and sporadic forms of central core disease are associated with mutations in the C-terminal domain of the skeletal muscle ryanodine receptor. Hum. Mol. Genet., 10, 2581-2592.
20. Tilgen, N., Zorzato, F., Halliger-Keller, B., Muntoni, F., Sewry, C., Palmucci, L.M., Schneider, C., Hauser, E., Lehmann-Horn, F., Müller, C.R. and Treves, S. (2001) Identification of four novel mutations in the C-terminal membrane spanning domain of the ryanodine receptor 1: association with central core disease and alteration of calcium homeostasis. Hum. Mol. Genet., 10, 2879-2887.
21. Zorzato, F., Yamaguchi, N., Xu, L., Meissner, G., Müller, C.R., Pouliquin, P., Muntoni, F., Sewry, C., Girard, T. and Treves, S. (2003) Clinical and functional effects of a deletion in a COOH-terminal lumenal loop of the skeletal muscle ryanodine receptor. Hum. Mol. Genet., 12, 379-388.
22. Treves, S., Larini, F., Menegazzi, P., Steinberg, T.H., Koval, M., Vilsen, B., Andersen, J.P. and Zorzato, F. (1994) Alteration of intracellular Ca2+ transients in COS-7 cells transfected with the cDNA encoding skeletal-muscle ryanodine receptor carrying a mutation associated with malignant hyperthermia. Biochem. J., 301, 661-665.
23. Otsu, K., Nishida, K., Kimura, Y., Kuzuya, T., Hori, M., Kamada, T. and Tada, M. (1994) The point mutation Arg615→Cys in the Ca2+ release channel of skeletal sarcoplasmic reticulum is responsible for hypersensitivity to caffeine and halothane in malignant hyperthermia. J. Biol. Chem., 269, 9413-9415.
24. Censier, K., Urwyler, A., Zorzato, F. and Treves, S. (1998) Intracellular calcium homeostasis in human primary muscle cells from malignant hyperthermia-susceptible and normal individuals. Effect Of overexpression of recombinant wild-type and Arg163Cys mutated ryanodine receptors. J. Clin. Invest., 101, 1233-1242.
25. Owen, V.J., Taske, N.L. and Lamb, G.D. (1997) Reduced Mg2+ inhibition of Ca2+ release in muscle fibers of pigs susceptible to malignant hyperthermia. Am. J. Physiol. Cell Physiol., 272, C203-C211.
26. Ducreux, S., Zorzato, F., Müller, C.R, Sewry, C., Muntoni, F., Quinlivan, R., Restagno, G., Girard, T. and Treves, S. (2004) Effect of ryanodine receptor mutations on IL-6 release and intracellular calcium homeostasis in human myotubes from malignant hyperthermia susceptible individuals and patients affected by central core disease. J. Biol. Chem., 279, 43838-43846.
27. Avila, G., O'Brien, J.J. and Dirksen, R.T. (2001) Excitation-contraction uncoupling by a human central core disease mutation in the ryanodine receptor. Proc. Natl Acad. Sci. USA, 98, 4215-4220.
28. Avila, G., O'Connell, K.M. and Dirksen, R.T. (2003) The pore region of the skeletal muscle ryanodine receptor is a primary locus for excitation-contraction uncoupling in central core disease. J. Gen. Physiol., 121, 277-286.
29. Lynch, P.J., Krivosic-Horber, R., Reyford, H., Moonier, N., Quane, K., Adnet, P., Haudecoeur, G., Krivosic, I., McCarthy, T. and Lunardi, J. (1997) Identification of heterozygous and homozygous individuals with the novel RYR1 mutation Cys35Arg in a large kindred. Anesthesiology, 86, 620-626.
30. Ducreux, S., Zorzato, F., Ferreiro, A., Jungbluth, H., Muntoni, F., Monnier, N., Müller, C.R. and Treves, S. (2006) Functional properties of ryanodine receptors carrying 3 amino acid substitutions identified in patients affected by multi-minicore disease and central core disease, expressed in immortalised lymphocytes. Biochem. J., 395, 259-266.
31. Gillard, E.F., Otsu, K., Fujii, J., Duff C., de Leon, S., Khanna, V.K., Britt, B.A., Worton, R.G. and MacLennan, D.H. (1992) Polymorphisms and deduced amino acid substitutions in the coding sequence of the ryanodine receptor (RYR1) gene in individuals with malignant hyperthermia. Genomics, 13, 1247-1254.
32. Sutko, J.L., Airey, J.A., Welch, W. and Ruest, L. (1997) The pharmacology of ryanodine and related compounds. Pharmacol. Rev, 49, 53-98.
33. Jungbluth, H., Sewry, C., Brown, S.C., Manzur, A.Y., Mercuri, E., Bushby, K., Rowe, P., Johnson, M.A., Hughes, I., Kelsey, A., Dubowitz, V. and Muntoni, F. (2000) Minicore myopathy in children - a clinical and histopathological study of 19 cases. Neuromuscul. Disord., 10, 264-273.
34. Ferreiro, A., Estournet, B., Chateau, D., Romero, N.B., Laroche, C., Odent, S., Toutain, A., Cabello, A., Fontan, D., dos Santos, H.G. et al. (2000) Multi-minicore disease - searching for boundaries: Phenotype analysis of 38 cases. Ann. Neurol., 48, 745-757.
35. Moonier, N., Ferreiro, A., Marty, I., Labarre-Vila, A., Mezin, P. and Lunardi, J. (2003) A homozygous splicing mutation causing depletion of skeletal muscle RYR1 is associated with multi-minicore disease congenital myopathy with ophthalmoplegia. Hum. Mol. Genet., 12, 1171-1178.
36. Lopez, J.R., Linares, N., Pessah, I.N. and Allen, P.D. (2005) Enhanced response to caffeine and 4-chloro-m-cresol in malignant hyperthermia-susceptible muscle is related in part to chronically elevated resting [Ca2+]i. Am. J. Physiol. Cell Physiol., 288, C606-C612.
37. Fessenden, J.D., Wang, Y., Moore, R.A., Chen, S.R., Allen, P.D. and Pessah, I.N. (2000) Divergent functional properties of ryanodine receptor type 1 and 3 expressed in a myogenic cell line. Biophys. J., 79, 2509-2525.
38. Matyash, M., Matyash, V., Nolte, C., Sorrentino, V. and Kettemnann, H. (2001) Requirement of functional ryanodine receptor type 3 for astrocyte migration. FASEB J., 16, 84-96.
39. Konig, S., Hinard, V., Arnaudeau, S., Holzer, N., Potter, G., Bader, C.R. and Bernheim, L. (2004) Membrane hyperpolarization triggers myogenin and myocyte enhancer factor-2 expression during human myoblast differentiation. J. Biol. Chem., 279, 28287-28296.
40. Bijlenga, P., Liu, J.H., Espinos, E., Haenggeli, C.A., Fischer-Lougheed, J., Bader, C.R. and Bernheim, L. (2000) T-type a1H Ca2+ channels are involved in Ca2+ signaling during terminal differentiation (fusion) of human myoblasts. Proc. Natl Acad. Sci. USA, 97, 7627-7632.
41. Jungbluth, H., Sewry, C., Brown, S.C., Manzur, A.Y., Mercuri, E., Bushby, K., Rowe, P., Johnson, M.A., Hughes, I., Kelsey, A., Dubowitz, V. and Muntoni, F. (2002) Minicore myopathy in children: A clinical and histopathological study of 19 cases. Neuromuscul. Disord., 10, 264-273.
42. Lattanzi, L., Salvatori, G., Coletta, M., Sonnino, C., Cusella De Angelis, M.G., Gioglio, L., Murry, C.E., Kelly, R., Ferrari, G., Molinaro, M. et al. (1998) High efficiency myogenic conversion of human fibroblasts by adenoviral vector-mediated MyoD gene transfer. An alternative strategy for ex vivo gene therapy of primary myopathies. J. Clin. Invest., 101, 2119-2128.
43. Gao, L., Balshaw, D., Xu, L., Tripathy, A., Xin, C. and Meissner, G. (2000) Evidence for a role of the lumenal M3-M4 loop in skeletal muscle Ca(2+) release channel (ryanodine receptor) activity and conductance. Biophys. J., 79, 828-840.
44. Takeshima, H. (1993) Primary structure and expression from cDNAs of the ryanodine receptor. Ann. NY Acad. Sci., 707, 165-177.
45. Xu, L., Wang, Y., Gillespie, D. and Meissner, G. (2006) Two rings of negative charges in the cytosolic vestibule of type-1 ryanodine receptor modulate ion fluxes. Biophys. J., 90, 443-453.